Hereditary neuroendocrine tumor of small intestine

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

No FDA or trial events recorded yet for Hereditary neuroendocrine tumor of small intestine.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

Patient Assistance Programs1

Detectnet

RadioMedix Inc.

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Detectnet

(copper Cu 64 dotatate)Orphan drugstandard

RadioMedix Inc.

Radioactive Diagnostic Agent [EPC]

12.1 Mechanism of Action Copper Cu 64 dotatate binds to somatostatin receptors with highest affinity for subtype 2 receptors (SSTR2). It binds to cell...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Hereditary neuroendocrine tumor of small intestine.
Search all trials →
Search clinical trials for Hereditary neuroendocrine tumor of small intestine

Recent News & Research

No recent news articles indexed yet for Hereditary neuroendocrine tumor of small intestine.
Search PubMed for Hereditary neuroendocrine tumor of small intestine

Browse all Hereditary neuroendocrine tumor of small intestine news →

Specialist Network

Top 6 by expertise

View all Hereditary neuroendocrine tumor of small intestine specialists →

Quick Actions